爱伦医疗
(920050)
| 流通市值：5.20亿 | | | 总市值：19.43亿 |
| 流通股本：1810.27万 | | | 总股本：6767.93万 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 641,650,456.84 | 294,537,632.66 | 988,730,443.01 | 689,622,115.17 |
| 营业收入 | 641,650,456.84 | 294,537,632.66 | 988,730,443.01 | 689,622,115.17 |
| 二、营业总成本 | 568,435,337.08 | 270,217,152.17 | 884,757,579.38 | 614,713,079.43 |
| 营业成本 | 483,277,118.95 | 226,965,563.22 | 767,835,978.91 | 538,186,909.4 |
| 税金及附加 | 4,547,188.83 | 2,350,558.74 | 7,874,591.48 | 5,313,354.35 |
| 销售费用 | 7,490,447.54 | 3,430,254.32 | 12,592,815.15 | 8,554,539.27 |
| 管理费用 | 45,971,281.9 | 23,450,194.03 | 82,848,724.76 | 53,526,166.77 |
| 研发费用 | 4,483,490.41 | 2,051,645.16 | 10,662,886.51 | 7,883,416.3 |
| 财务费用 | 22,665,809.45 | 11,968,936.7 | 2,942,582.57 | 1,248,693.34 |
| 其中:利息费用 | 3,631,095.16 | 1,767,360.46 | 5,439,369.85 | 3,658,401.55 |
| 其中:利息收入 | 397,061.66 | 162,094.46 | 350,882.81 | 233,812.98 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 0 | 0 | -805.68 | -805.68 |
| 加:投资收益 | 8,185.57 | 849.84 | 144,061.14 | 161,920.13 |
| 资产处置收益 | -27,110.09 | - | -6,774.08 | -6,774.08 |
| 资产减值损失(新) | -11,298,226.86 | -2,164,201.82 | -6,377,014.06 | -1,654,341.35 |
| 信用减值损失(新) | -1,445,195.75 | 1,069,039.09 | -216,670.29 | 127,652.41 |
| 其他收益 | 776,617.37 | 298,988.97 | 5,290,385.55 | 4,091,998.38 |
| 四、营业利润 | 61,229,390 | 23,525,156.57 | 102,806,046.21 | 77,628,685.55 |
| 加:营业外收入 | 1,255,265.48 | 39,602.9 | 84,748.09 | 74,588.22 |
| 减:营业外支出 | 2,949,302.39 | 5,366.66 | 908,396.41 | 583,688.66 |
| 五、利润总额 | 59,535,353.09 | 23,559,392.81 | 101,982,397.89 | 77,119,585.11 |
| 减:所得税费用 | 2,238,999.53 | 2,179,593.87 | 8,490,871.34 | 4,032,982.42 |
| 六、净利润 | 57,296,353.56 | 21,379,798.94 | 93,491,526.55 | 73,086,602.69 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 57,296,353.56 | 21,379,798.94 | 93,491,526.55 | 73,086,602.69 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 62,677,845.41 | 24,572,471.33 | 94,086,713.64 | 73,479,026.58 |
| 少数股东损益 | -5,381,491.85 | -3,192,672.39 | -595,187.09 | -392,423.89 |
| 扣除非经常损益后的净利润 | 63,529,039.72 | 24,325,952.47 | 90,166,847.83 | 70,275,453.3 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.97 | 0.4 | 1.85 | 1.45 |
| (二)稀释每股收益 | 0.98 | 0.39 | 1.78 | - |
| 八、其他综合收益 | -22,224,125.59 | -14,249,850.65 | 10,119,796.38 | 8,683,702.91 |
| 归属于母公司股东的其他综合收益 | -22,224,125.59 | -14,249,850.65 | 10,119,796.38 | 8,683,702.91 |
| 九、综合收益总额 | 35,072,227.97 | 7,129,948.29 | 103,611,322.93 | 81,770,305.6 |
| 归属于母公司股东的综合收益总额 | 40,453,719.82 | 10,322,620.68 | 104,206,510.02 | 82,162,729.49 |
| 归属于少数股东的综合收益总额 | -5,381,491.85 | -3,192,672.39 | -595,187.09 | -392,423.89 |
| 公告日期 | 2026-07-31 | 2026-04-24 | 2026-04-24 | 2025-10-30 |
| 审计意见(境内) | | | 标准无保留意见 | |